A citation-based method for searching scientific literature

Mary Jo Lund, Katrina F Trivers, Peggy L Porter, Ralph J Coates, Brian Leyland-Jones, Otis W Brawley, Elaine W Flagg, Ruth M O'Regan, Sheryl G A Gabram, J William Eley. Breast Cancer Res Treat 2009
Times Cited: 276

Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler, Lars A Akslen, Joseph Ragaz, Allen M Gown, C Blake Gilks, Matt van de Rijn, Charles M Perou. Clin Cancer Res 2004
Times Cited: 1903

List of shared articles

Times cited

Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer.
Zhen Wang, Lei Liu, Ying Li, Zi'an Song, Yi Jing, Ziyu Fan, Sheng Zhang. Front Oncol 2021

Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis.
Pengzhi Dong, Bing Yu, Lanlan Pan, Xiaoxuan Tian, Fangfang Liu. Biomed Res Int 2018

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes.
Heloisa H Milioli, Inna Tishchenko, Carlos Riveros, Regina Berretta, Pablo Moscato. BMC Med Genomics 2017

Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer.
Aziza E Abdelrahman, Hayam E Rashed, Mohamed Abdelgawad, Mohamed I Abdelhamid. Ann Diagn Pathol 2017

Novel therapeutic strategies in the treatment of triple-negative breast cancer.
Karima Oualla, Heba M El-Zawahry, Banu Arun, James M Reuben, Wendy A Woodward, Heba Gamal El-Din, Bora Lim, Nawfel Mellas, Naoto T Ueno, Tamer M Fouad. Ther Adv Med Oncol 2017

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.
Jennifer A Crozier, Pooja P Advani, Betsy LaPlant, Timothy Hobday, Anthony J Jaslowski, Alvaro Moreno-Aspitia, Edith A Perez. Clin Breast Cancer 2016